International Clinical Trial: Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122089) titled 'Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis' on Aug. 7.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Center Eugene Marquis

Condition: Hepatocellular Carcinoma Non-resectable

Intervention: Device: Selective Internal Radiotherapy Drug: Tremelimumab

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: January 2, 2026

Target Sample Size: 80

To know more, visit https://clinicaltrials.go...